|Other names||Arformoterol tartrate (USAN US)|
|Elimination half-life||26 hours|
|CompTox Dashboard (EPA)|
|Chemical and physical data|
|Molar mass||344.411 g·mol−1|
|(what is this?)|
Arformoterol, sold under the brand name Brovana among others, is a medication used for the treatment of chronic obstructive pulmonary disease (COPD).
It is a long-acting β2 adrenoreceptor agonist (LABA) and it is the active (R,R)-(−)-enantiomer of formoterol. It was approved for medical use in the United States in October 2006. It is available as a generic medicine.
Arformoterol is indicated for the maintenance treatment of bronchoconstriction in people with chronic obstructive pulmonary disease (COPD).